Physician profile
Kelly Ryan
NPI 1235690249
$4,613.61
in general payments reported to CMS, 2019-2025
9 companies · $1,346 in 2025
The $1,346 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.20 · 2020: $325 · 2021: $41.74 · 2023: $122 · 2024: $2,763 · 2025: $1,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,500 · Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,500.00 |
| Food and Beverage | $731.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,603.12 | 2024-2025 | |
| Medical Device Business Services, INC. | $362.39 | 2019-2021 | |
| Hologic Sales and Service, LLC | $204.06 | 2021-2025 | Myosure Tissue Removal Device, Acessa Provu System |
| Axonics, INC. | $147.76 | 2024 | Bulkamid, Axonics |
| Sumitomo Pharma America, INC. | $122.32 | 2023 | Myfembree |
| Ethicon US, LLC | $71.45 | 2024-2025 | Harmonic, Stratafix |
| Baxter Healthcare | $56.77 | 2025 | Tisseel |
| Astellas Pharma US INC | $25.87 | 2025 | Veozah |
| Davol INC. | $19.87 | 2024 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.